MATWIN’s platform objectives
MATWIN (Maturation & Accelerating Translation With Industry) is the only French open-innovation platform specifically dedicated to oncology. MATWIN, a wholly owned subsidiary of Unicancer group (gathering all the French Comprehensive Cancer Centres) offers several actions (expertise, accelerating program, events, etc.) aiming at accelerating the development of innovative projects dedicated to the fight against cancer.
Research
Strenghten innovations’ transfer potential in partnership with the national ecosystem (canceropôles, TTOs, clusters …
Industry
Mutualize a sourcing platform of « shortlisted » early innovative projects
Patients
Contribute to accelerate treatments/ diagnostics outlooks
How to work with MATWIN ?
MATWIN in figures
supported projects
projects interviewed by the board
start-up created
projects transferred
MEET2WIN participants
MEET2WIN : our annual partnering convention dedicated to open innovation in oncology
News
MATWIN is hiring a R&D Project Manager (Oncology)
You dream of taking part in an exciting and meaningful adventure, of joining a start-up like team willing to accelerate [...]
MATWIN BOARD MEETING 2023
A unique committee in Europe, the MATWIN Board is made up of around twenty international R&D decision-makers from the World [...]
PR: MATWIN highlights about thirty innovative projects to tackle cancer
Download the press release: